spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PCI Welcomes Al Moss as Philadelphia General Manager


Philadelphia, PA – September 26, 2017 – PCI Pharma Services (PCI) is pleased to announce that Al Moss has assumed the role of Vice President and General Manager of its Philadelphia, PA location. The site serves as PCI’s corporate headquarters as well as a Center of Excellence for contract packaging services for commercial medicines, medical devices and consumer healthcare products. PCI operates an extensive global supply network across North America and Europe, supporting medicines destined to over 100 countries worldwide.

Al comes to PCI with outstanding credentials and a proven record of results, holding progressive leadership positions at industry-leading companies including Procter and Gamble, General Mills, SABMiller, British Petroleum (BP) and most recently at Coty, Inc. where he led North American Skincare and Fragrance Operations. His track record of demonstrated success throughout his career spans virtually all elements of supply chain, including distribution and warehousing, logistics and transportation, supplier enablement, production, and customer capability development. In addition to his professional experience, Al holds a Bachelor’s degree in Industrial and Systems Engineering from North Carolina A&T State University, an MBA in Operations Management from the University of Iowa, and a Master’s Degree in Supply Chain Management from Penn State.

"We are very excited to have Al join the PCI team," stated Bill Mitchell, Chief Executive Officer. “Al brings a diverse background in supply chain and production and truly understands the needs of our customers. His personal commitment to customer satisfaction underscores the company's focus on true strategic partnership and providing the industry’s leading customer experience. Al's demonstrated leadership has him well positioned to lead the Philadelphia team."

The PCI Philadelphia facility recently expanded site capacity by adding additional high speed bottling and blister packaging lines, as well as a significant expansion of its Serialization capacity, part of a multi-site installation that will have PCI realize more than 80 lines of Serialization readiness. Other notable capital investments include the expansion of the site’s 2-8C Cold Chain storage, adding to the Cold Chain capabilities at the Rockford, IL and Bridgend, UK facilities. This is the latest in a series of significant investments by PCI to facilitate their strategic expansion of services, positioning PCI to best support trends in the pharmaceutical marketplace.

About PCI

The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global development needs throughout the product life cycle — from Phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.

Al Moss

 
Print this page
Send to a friend
   
spacer
News and Press Releases

Countdown to the UK’s leading production line event begins

In light of Nick Peters’, author of the Annual Manufacturing report 2018, comment that “UK manufacturing has come a long way in recent years, as we have seen from their stellar performance in 2017,” it’s no surprise that the PPMA Show is gearing up for its biggest show to date when it returns to the NEC, Birmingham, between 25-27 September 2018.
More info >>


White Papers

Speciality Logistics Outlook 2015

World Courier

To date, there are more than 178,000 registered clinical trials taking place across the globe, and global pharma’s volume has more than doubled over the last decade. With emerging markets showing explosive predictive growth through 2016, shippers and trial sponsors can expect continued regulatory and overall logistics complexities that foster demand for local, inmarket resources across the globe.
More info >>

Industry Events

Viral Safety and Raw Materials

23-25 April 2018, RAI, Amsterdam

Viral Safety and Raw Materials 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement